These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 12908216
21. No money, no meds. Mabry M. Newsweek; 1999 Jul 12; 134(2):32-3. PubMed ID: 10538648 [No Abstract] [Full Text] [Related]
22. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada. Openshaw MS. Nurs Econ; 2005 Jul 12; 23(6):307-11, 279. PubMed ID: 16459902 [Abstract] [Full Text] [Related]
23. Any willing provider meets the formulary. Barrueta A. Health Syst Rev; 1995 Jul 12; 28(4):20, 22-3. PubMed ID: 10144359 [Abstract] [Full Text] [Related]
25. Proposal to regulate formularies draws sharp difference of opinion. Carlson B. Manag Care; 2002 Feb 12; 11(2):34-8. PubMed ID: 11904911 [No Abstract] [Full Text] [Related]
26. Next wave of change in managed health care will sweep away antiquated prescription practices. Weishar G. Health Care Innov; 1997 Feb 12; 7(1):8-13. PubMed ID: 10165129 [No Abstract] [Full Text] [Related]
27. Time to leave the capsule ... if you dare. McCarthy R. Bus Health; 1991 Sep 12; 9(9):22-3, 26, 28 passim. PubMed ID: 10112859 [Abstract] [Full Text] [Related]
28. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E. Chic J Int Law; 2002 Sep 12; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
29. Legalized importation of Canadian prescription drugs: short-term solution to a long-term problem. Teufel AT. J Contemp Health Law Policy; 2006 Sep 12; 22(2):383-408. PubMed ID: 17117702 [No Abstract] [Full Text] [Related]
30. By the numbers. The rising costs of prescription drugs. Thornton D. Healthplan; 1999 Sep 12; 40(5):71-2. PubMed ID: 10622972 [No Abstract] [Full Text] [Related]
32. Economic and policy implications of reimportation: a Canadian perspective. Ward C. Manag Care; 2004 Mar 12; 13(3 Suppl):17-20. PubMed ID: 15074165 [No Abstract] [Full Text] [Related]
33. If foreign drug prices go up, will U.S. prices come down? Med Health; 2003 Dec 15; 57(45):2-4. PubMed ID: 14723168 [No Abstract] [Full Text] [Related]
34. Providing health economic data to managed care. Navarro RP. Manag Care Interface; 1998 Sep 15; 11(9):62-3, 66. PubMed ID: 10187588 [No Abstract] [Full Text] [Related]
35. Who's really raising drug prices? Zagorin A. Time; 1999 Mar 08; 153(9):46-8. PubMed ID: 10346086 [No Abstract] [Full Text] [Related]
37. Changing the marketing message. Navarro RP. Med Interface; 1995 Jun 08; 8(6):83-5. PubMed ID: 10142946 [No Abstract] [Full Text] [Related]
38. User applications of health economics data. Navarro RP. Med Interface; 1996 Mar 08; 9(3):81-2. PubMed ID: 10156017 [No Abstract] [Full Text] [Related]
39. Is the market ready for direct pharmaceutical contracting by employers? Giaquinta D. Manag Care Interface; 2004 Aug 08; 17(8):33-4. PubMed ID: 15471109 [No Abstract] [Full Text] [Related]
40. Prescription costs become harder to swallow. Providers and payers get a big dose of reality with explosive spending and patient demand for new drugs. Hensley S. Mod Healthc; 1999 Aug 23; 29(34):30-4. PubMed ID: 10557476 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]